Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zhang, Yaming
NCT03941561: S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC）	Recruiting	3	1006	RoW	S-1 for 9 months, Tegafur,Gimeracil and Oteracil Porassium Capsules, S-1 for 1 year	Fudan University	Gastric Cancer	01/22	05/27
NCT03399253: Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor	Recruiting	3	120	RoW	surgery, chemotherapy, XELOX	Sun Yat-sen University	Gastric Cancer	11/22	12/25
NCT03399110: XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)	Active, not recruiting	3	1032	RoW	Oxaliplatin, Eloxatin, Capecitabine, Xeloda	Fudan University	Gastric Cancer	08/26	08/26